These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16953544)

  • 41. [Developing a Clinical Performance Measures System for hemodialysis, Quality Group, Spanish Society of Nephrology].
    López Revuelta K; Barril G; Caramelo C; Delgado R; García López F; García Valdecasas J; Gruss E; Jiménez Almonacid P; Martínez Castelao A; Luis Miguel J; Ortiz A; Del Pino Y Pino MD; Portolés JM; Prados C; Sanz P; Tato A; Alvarez Ude F; Angoso M; Aranaz J; Arenas MD; Lorenzo S;
    Nefrologia; 2007; 27(5):542-59. PubMed ID: 18045030
    [No Abstract]   [Full Text] [Related]  

  • 42. Bioethics in nephrology: guidelines for decision-making in Italy.
    Buzzi F; Cecioni R; Di Paolo M;
    J Nephrol; 2001; 14(2):93-7. PubMed ID: 11411020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-sectional comparison of quality of life and illness intrusiveness in patients who are treated with nocturnal home hemodialysis versus peritoneal dialysis.
    Fong E; Bargman JM; Chan CT
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1195-200. PubMed ID: 17928469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 2006 K/DOQI guidelines for peritoneal dialysis adequacy are not adequate.
    Winchester JF; Harbord N; Audia P; Dubrow A; Gruber S; Feinfeld D; Amerling R
    Blood Purif; 2007; 25(1):103-5. PubMed ID: 17170545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [When to start dialysis. The predialysis patient].
    Triolo G; Savoldi S
    G Ital Nefrol; 2008; 25 Suppl 41():S9-12, discussion S13-20. PubMed ID: 18473314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Survey of hidden costs of dialysis in Italian for-profit and not-for-profit centers.
    Bellizzi V; Perrone F; Terracciano V; Cucciniello E; Stanzione G; D'Angiò P; De Nicola L; Di Iorio B
    J Nephrol; 2008; 21(6):894-9. PubMed ID: 19034874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nephrology].
    Hadaya K; Marangon N; Stoermann Chopard C; Martin PY
    Rev Med Suisse; 2007 Jan; 3(93):35-8. PubMed ID: 17354659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assisted peritoneal dialysis: what is it and who does it involve?
    Dimkovic N; Aggarwal V; Khan S; Chu M; Bargman J; Oreopoulos DG
    Adv Perit Dial; 2009; 25():165-70. PubMed ID: 19886339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The resurgence of home dialysis therapies.
    Moran J
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):284-9. PubMed ID: 17603983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guidelines of the Peritoneal Dialysis Study Group of the Italian Society of Nephrology.
    Corciulo R; La Milia V
    J Nephrol; 2013; 26 Suppl 21():2-3. PubMed ID: 24307438
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pregnancy in patients treated with hemodialysis and peritoneal dialysis: review of the literature and management guidelines].
    Sefer S; Vrsalović M; Degoricija V; Starcević M; Ratković-Gusić I; Delmis J
    Lijec Vjesn; 2002; 124(3-4):82-8. PubMed ID: 18956826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative studies of dialysis therapies should reflect real world decision-making.
    Quinn RR; Austin PC; Oliver MJ
    J Nephrol; 2008; 21(2):139-45. PubMed ID: 18446707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The economics of home dialysis: acting for the individual while planning responsibly for the population.
    Komenda P; Sood MM
    Adv Chronic Kidney Dis; 2009 May; 16(3):198-204. PubMed ID: 19393970
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Unawareness of the K/DOQI guidelines for bone and mineral metabolism in predialysis chronic kidney disease: results of the OSERCE Spanish multicenter-study survey].
    Bover J; Górriz JL; Martín de Francisco AL; Caravaca F; Barril G; Molinero LM;
    Nefrologia; 2008; 28(6):637-43. PubMed ID: 19016638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Practice guidelines do improve patient outcomes: association or causation?
    Levin A
    Blood Purif; 2008; 26(1):67-72. PubMed ID: 18182800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assisted peritoneal dialysis.
    Povlsen JV; Ivarsen P
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):279-83. PubMed ID: 17603982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Provision and quality of dialysis services in Libya.
    Alashek WA; McIntyre CW; Taal MW
    Hemodial Int; 2011 Oct; 15(4):444-52. PubMed ID: 22111812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interventional nephrology: from episodic to coordinated vascular access care.
    Asif A; Besarab A; Roy-Chaudhury P; Spergel LM; Ravani P
    J Nephrol; 2007; 20(4):399-405. PubMed ID: 17879204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.